Free Trial

SAB Biotherapeutics (SABS) Short Interest Ratio & Short Volume

SAB Biotherapeutics logo
$2.32 +0.20 (+9.43%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$2.19 -0.13 (-5.56%)
As of 07:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SAB Biotherapeutics Short Interest Data

SAB Biotherapeutics (SABS) has a short interest of 502,000 shares, representing 5.98% of the float (the number of shares available for trading by the public). This marks a -32.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 86,240 shares to cover all short positions.

Current Short Interest
502,000 shares
Previous Short Interest
745,600 shares
Change Vs. Previous Month
-32.67%
Dollar Volume Sold Short
$1.11 million
Short Interest Ratio
0.4 Days to Cover
Last Record Date
August 15, 2025
Outstanding Shares
10,410,000 shares
Float Size
8,390,000 shares
Short Percent of Float
5.98%
Today's Trading Volume
105,820 shares
Average Trading Volume
86,240 shares
Today's Volume Vs. Average
123%
Short Selling SAB Biotherapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for SAB Biotherapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

SABS Short Interest Over Time

SABS Days to Cover Over Time

SABS Percentage of Float Shorted Over Time

SAB Biotherapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/15/2025502,000 shares $1.11 million -32.7%6.0%0.4 $2.22
7/31/2025745,600 shares $1.40 million +3,433.7%8.9%0.5 $1.88
7/15/202521,100 shares $53.59 thousand -0.9%0.3%0 $2.54
6/30/202521,300 shares $37.38 thousand -37.0%0.3%0.5 $1.76
6/15/202533,800 shares $57.80 thousand -8.2%0.5%0.8 $1.71
5/31/202536,800 shares $68.82 thousand -48.9%0.5%0.8 $1.87
5/15/202572,000 shares $139.68 thousand -27.9%1.0%1.4 $1.94
4/30/202599,900 shares $169.83 thousand +39.7%1.3%1.8 $1.70
4/15/202571,500 shares $98.24 thousand -22.9%1.0%0.7 $1.37
3/31/202592,700 shares $126.07 thousand -19.4%1.2%0.9 $1.36
3/15/2025115,000 shares $185.15 thousand -8.0%1.6%1 $1.61
2/28/2025125,000 shares $213.75 thousand +84.6%1.7%1 $1.71
2/15/202567,700 shares $134.05 thousand -42.8%0.9%0.5 $1.98
1/31/2025118,400 shares $259.30 thousand +121.3%1.6%1 $2.19
1/15/202553,500 shares $186.18 thousand +46.6%0.7%0.7 $3.48
12/31/202436,500 shares $138.34 thousand -35.3%0.5%0.4 $3.79
12/15/202456,400 shares $230.11 thousand -43.0%0.8%0.6 $4.08
11/30/202499,000 shares $289.08 thousand +148.1%1.3%1.1 $2.92
11/15/202439,900 shares $123.69 thousand -32.1%0.5%0.5 $3.10
10/31/202458,800 shares $191.69 thousand -26.3%0.8%0.9 $3.26
10/15/202479,800 shares $193.12 thousand +92.3%1.1%1.6 $2.42
9/30/202441,500 shares $112.05 thousand +37.4%0.6%2.3 $2.70
9/15/202430,200 shares $84.26 thousand -12.7%0.4%1.9 $2.79
8/31/202434,600 shares $101.72 thousand +32.1%0.5%3.7 $2.94
8/15/202426,200 shares $58.95 thousand -8.1%0.4%2.6 $2.25
7/31/202428,500 shares $79.09 thousand +8.0%0.4%1.7 $2.78
7/15/202426,400 shares $76.56 thousand -17.0%0.4%1.6 $2.90
6/30/202431,800 shares $98.58 thousand -7.0%0.4%2 $3.10
6/15/202434,200 shares $107.73 thousand +0.9%0.5%2.1 $3.15
5/31/202433,900 shares $89.50 thousand +50.7%0.5%1.9 $2.64
5/15/202422,500 shares $88.43 thousand No Change0.3%1.2 $3.93
4/30/202422,500 shares $96.53 thousand -12.1%0.3%1.7 $4.29
4/15/202425,600 shares $111.62 thousand -11.4%0.3%1.8 $4.36
3/31/202428,900 shares $131.21 thousand +38.3%0.4%1.7 $4.54
3/15/202420,900 shares $115.37 thousand -15.0%0.3%1.1 $5.52
2/29/202424,600 shares $109.72 thousand -37.1%0.3%1.5 $4.46
2/15/202439,100 shares $217.01 thousand +17.8%0.5%2.9 $5.55
1/31/202433,200 shares $199.20 thousand +90.8%0.4%2.8 $6.00
1/15/202417,400 shares $104.05 thousand -2.8%0.2%1.5 $5.98
12/31/202317,900 shares $12.31 thousand -91.4%N/A2.1 $0.69
Crypto Income (almost instantly) (Ad)

How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? Depending on when you watch this new training, crypto income could be hitting your account as early as tonight!tc pixel

12/15/2023207,600 shares $153.29 thousand -11.2%0.3%3 $0.74
11/30/2023233,700 shares $227.16 thousand +1.7%0.7%3.8 $0.97
11/15/2023229,800 shares $209.12 thousand -12.1%0.6%4.4 $0.91
10/31/2023261,400 shares $261.37 thousand -2.2%0.7%5.2 $1.00
10/15/2023267,200 shares $187.57 thousand -2.8%0.7%6.4 $0.70
9/30/2023274,900 shares $173.19 thousand -10.3%0.7%7.4 $0.63
9/15/2023306,500 shares $199.23 thousand -17.5%0.8%8.5 $0.65
8/31/2023371,600 shares $267.55 thousand +8.8%1.0%7 $0.72
8/15/2023341,500 shares $269.79 thousand -12.3%0.9%5.9 $0.79
7/31/2023389,300 shares $315.33 thousand -12.4%1.1%4.7 $0.81
7/15/2023444,400 shares $385.47 thousand -4.1%1.3%1.6 $0.87
6/30/2023463,200 shares $384.46 thousand +27.2%1.3%0.3 $0.83
6/15/2023364,300 shares $329.69 thousand -14.9%1.0%0.3 $0.91
5/31/2023428,100 shares $381.01 thousand -35.7%1.2%0.3 $0.89
5/15/2023665,400 shares $585.55 thousand +28.3%1.9%0.5 $0.88
4/30/2023518,600 shares $465.86 thousand +287.6%1.5%0.4 $0.90
4/15/2023133,800 shares $97.07 thousand -3.2%0.4%0.1 $0.73
3/31/2023138,200 shares $60.81 thousand -30.1%0.4%3.4 $0.44
3/15/2023197,800 shares $100.88 thousand +17.5%0.6%4.3 $0.51
2/28/2023168,300 shares $109.40 thousand +14.1%0.5%3.2 $0.65
2/15/2023147,500 shares $97.79 thousand -2.8%0.5%2.7 $0.66
1/31/2023151,700 shares $103.06 thousand +3.1%0.5%2.3 $0.68
1/15/2023147,100 shares $109.43 thousand -14.4%0.5%2.1 $0.74
12/30/2022171,800 shares $101.34 thousand -14.4%0.6%2.5 $0.59
12/15/2022200,700 shares $184.68 thousand -6.1%0.7%2.8 $0.92
11/30/2022213,700 shares $230.80 thousand -11.1%0.8%2.8 $1.08
11/15/2022240,300 shares $254.72 thousand +8.2%0.9%3.1 $1.06
10/31/2022222,200 shares $199.98 thousand -15.3%0.8%3.1 $0.90
10/15/2022262,400 shares $208.63 thousand +7.7%0.9%3.8 $0.80
9/30/2022243,600 shares $170.76 thousand +22.8%0.9%3.6 $0.70
9/15/2022198,300 shares $164.59 thousand -22.1%0.7%3.6 $0.83
8/31/2022254,600 shares $178.25 thousand +6.3%1.0%4.5 $0.70
8/15/2022239,500 shares $287.40 thousand -6.4%0.9%4.9 $1.20
7/31/2022255,900 shares $276.37 thousand -3.4%1.0%5.3 $1.08
7/15/2022265,000 shares $315.35 thousand -8.8%1.0%5.7 $1.19
6/30/2022290,700 shares $421.52 thousand +17.1%1.1%4.5 $1.45
6/15/2022248,300 shares $330.24 thousand -19.8%1.0%1.2 $1.33
5/31/2022309,600 shares $606.82 thousand +19.8%1.2%1.5 $1.96
5/15/2022258,500 shares $514.42 thousand -2.5%1.1%1.1 $1.99
4/30/2022265,100 shares $662.75 thousand +3.7%1.1%1.2 $2.50
4/15/2022255,700 shares $736.42 thousand -12.8%1.0%1.1 $2.88
3/31/2022293,200 shares $1.10 million -6.7%1.2%1.3 $3.76
3/15/2022314,400 shares $572.21 thousand -30.0%1.3%2.9 $1.82
2/28/2022449,000 shares $2.23 million -5.9%1.8%2.7 $4.96
2/15/2022477,000 shares $2.57 million -0.1%1.9%2.3 $5.39
1/31/2022477,400 shares $2.77 million +19.7%1.9%1.9 $5.81
1/15/2022398,700 shares $2.69 million -26.9%1.6%1 $6.75
12/31/2021545,400 shares $4.26 million No Change2.2%0.8 $7.81

SABS Short Interest - Frequently Asked Questions

What is SAB Biotherapeutics' current short interest?

Short interest is the volume of SAB Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 502,000 shares of SABS short. 5.98% of SAB Biotherapeutics' shares are currently sold short. Learn More on SAB Biotherapeutics' current short interest.

What is a good short interest percentage for SAB Biotherapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.98% of SAB Biotherapeutics' floating shares are currently sold short.

Is SAB Biotherapeutics' short interest increasing or decreasing?

SAB Biotherapeutics saw a drop in short interest in the month of August. As of August 15th, there was short interest totaling 502,000 shares, a drop of 32.7% from the previous total of 745,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is SAB Biotherapeutics' float size?

SAB Biotherapeutics currently has issued a total of 10,410,000 shares. Some of SAB Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. SAB Biotherapeutics currently has a public float of 8,390,000 shares.

How does SAB Biotherapeutics' short interest compare to its competitors?

5.98% of SAB Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to SAB Biotherapeutics: Fortress Biotech, Inc. (13.12%), Curis, Inc. (1.57%), Bolt Biotherapeutics, Inc. (5.79%), Amgen Inc. (2.02%), Gilead Sciences, Inc. (1.47%), Vertex Pharmaceuticals Incorporated (1.45%), Regeneron Pharmaceuticals, Inc. (2.30%), Alnylam Pharmaceuticals, Inc. (2.62%), Biogen Inc. (2.84%), United Therapeutics Corporation (6.54%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks.

What does it mean to sell short SAB Biotherapeutics stock?

Short selling SABS is an investing strategy that aims to generate trading profit from SAB Biotherapeutics as its price is falling. SABS shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against SAB Biotherapeutics?

A short squeeze for SAB Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SABS, which in turn drives the price of the stock up even further.

How often is SAB Biotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SABS, twice per month. The most recent reporting period available is August, 15 2025.




This page (NASDAQ:SABS) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners